1
|
Bognár SA, Teutsch B, Bunduc S, Veres DS, Szabó B, Fogarasi B, Zahariev OJ, Vörhendi N, Almog O, Hadani Y, Gergő D, Mihály E, Erőss B, Bunduc S, Márta K, Hegyi P. Psychological intervention improves quality of life in patients with early-stage cancer: a systematic review and meta-analysis of randomized clinical trials. Sci Rep 2024; 14:13233. [PMID: 38853187 PMCID: PMC11162999 DOI: 10.1038/s41598-024-63431-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/03/2023] [Accepted: 05/29/2024] [Indexed: 06/11/2024] Open
Abstract
The effectiveness of psychological interventions (PI) for malignant diseases is controversial. We aimed to investigate the effect of PI on survival and quality of life (QoL) in patients with cancer. We performed a systematic search of MEDLINE, Cochrane, and Embase databases to identify randomized controlled trials comparing PI to standard care (PROSPERO registration number CRD42021282327). Outcomes were overall survival (OS), recurrence-free survival (RFS), and different domains of QoL. Subgroup analysis was performed based on the provider-, type-, environment-, duration of intervention; cancer stage, and type. Pooled hazard ratios (HR) and standardized mean difference (SMD) with 95% confidence intervals (CI) were calculated using a random-effects model. The OS and RFS did not differ significantly between the two groups (OS:HR = 0.97; CI 0.87-1.08; RFS:HR = 0.99; CI 0.84-1.16). However, there was significant improvement in the intervention group in all the analyzed domains of QoL; in the global (SMD = 0.65; CI 0.35-0.94), emotional (SMD = 0.64; CI 0.33-0.95), social (SMD = 0.32; CI 0.13-0.51) and physical (SMD = 0.33; CI 0.05-0.60) domains. The effect of PI on QoL was generally positive immediately, 12 and 24 weeks after intervention, but the effect decreased over time and was no longer found significant at 48 weeks. The results were better in the breast cancer group and early stages of cancer. PIs do not prolong survival, but they significantly improve the QoL of cancer patients. PI should be added as standard of care 3-4 times a year, at least for patients with early-stage cancer.
Collapse
Affiliation(s)
- Sára Anna Bognár
- Institute of Pancreatic Diseases, Semmelweis University, 1083, Budapest, Hungary
- Centre for Translational Medicine, Semmelweis University, 1085, Budapest, Hungary
| | - Brigitta Teutsch
- Centre for Translational Medicine, Semmelweis University, 1085, Budapest, Hungary
- Institute for Translational Medicine, Medical School, University of Pécs, 7623, Pecs, Hungary
| | - Stefania Bunduc
- Centre for Translational Medicine, Semmelweis University, 1085, Budapest, Hungary
| | - Dániel Sándor Veres
- Centre for Translational Medicine, Semmelweis University, 1085, Budapest, Hungary
- Department of Biophysics and Radiation Biology, Semmelweis University, 1085, Budapest, Hungary
| | - Bence Szabó
- Centre for Translational Medicine, Semmelweis University, 1085, Budapest, Hungary
| | - Beatrix Fogarasi
- Institute of Pancreatic Diseases, Semmelweis University, 1083, Budapest, Hungary
| | - Olga Júlia Zahariev
- Institute of Pancreatic Diseases, Semmelweis University, 1083, Budapest, Hungary
- Centre for Translational Medicine, Semmelweis University, 1085, Budapest, Hungary
| | - Nóra Vörhendi
- Institute for Translational Medicine, Medical School, University of Pécs, 7623, Pecs, Hungary
- Department of Internal Medicine, Siófok City Hospital and Outpatient Clinic, 8601, Siófok, Hungary
| | - Omer Almog
- Centre for Translational Medicine, Semmelweis University, 1085, Budapest, Hungary
| | - Yael Hadani
- Centre for Translational Medicine, Semmelweis University, 1085, Budapest, Hungary
| | - Dorottya Gergő
- Centre for Translational Medicine, Semmelweis University, 1085, Budapest, Hungary
- Department of Pharmacognosy, Semmelweis University, Üllői út 26, 1085, Budapest, Hungary
| | - Emese Mihály
- Department of Internal Medicine and Hematology, Medical School, Semmelweis University, 1088, Budapest, Hungary
| | - Bálint Erőss
- Institute of Pancreatic Diseases, Semmelweis University, 1083, Budapest, Hungary
- Centre for Translational Medicine, Semmelweis University, 1085, Budapest, Hungary
- Institute for Translational Medicine, Medical School, University of Pécs, 7623, Pecs, Hungary
| | - Stefania Bunduc
- Centre for Translational Medicine, Semmelweis University, 1085, Budapest, Hungary
- Center for Digestive Diseases and Liver Transplant, Fundeni Clinical Institute, 022328, Bucharest, Romania
| | - Katalin Márta
- Institute of Pancreatic Diseases, Semmelweis University, 1083, Budapest, Hungary
- Centre for Translational Medicine, Semmelweis University, 1085, Budapest, Hungary
- Translational Pancreatology Research Group, Interdisciplinary Centre of Excellence for Research Development and Innovation University of Szeged, 6725, Szeged, Hungary
| | - Péter Hegyi
- Institute of Pancreatic Diseases, Semmelweis University, 1083, Budapest, Hungary.
- Centre for Translational Medicine, Semmelweis University, 1085, Budapest, Hungary.
- Institute for Translational Medicine, Medical School, University of Pécs, 7623, Pecs, Hungary.
- Translational Pancreatology Research Group, Interdisciplinary Centre of Excellence for Research Development and Innovation University of Szeged, 6725, Szeged, Hungary.
| |
Collapse
|
2
|
Nayiga BK, Abrams SW, Rhayel A, Edward H, Tang A, Kho ME, Sebestien H, Smith-Turchyn J. Exploring the use of rehabilitation in individuals with head and neck cancer undergoing treatment: a scoping review. Disabil Rehabil 2024:1-21. [PMID: 38494954 DOI: 10.1080/09638288.2024.2328810] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/21/2023] [Accepted: 03/06/2024] [Indexed: 03/19/2024]
Abstract
Explore the use, characteristics, feasibility, and functional outcomes of rehabilitation interventions used for individuals with head and neck cancer (HNC) during treatment. Searches were conducted in four databases from Jan 2011 to Dec 31, 2022. Included studies had to include adults with HNC undergoing treatment, a rehabilitation intervention, an assessment of functional outcome(s) addressed by the International Classification of Functioning Framework (ICF) and be published in English language. Title and abstract screening, full-text review, and data extraction were completed independently, in duplicate. Descriptive statistics and a qualitative synthesis summarized findings. Twenty-seven studies were included in this review. The majority of studies were randomized controlled trials (70%). Most individuals represented in the included studies were males (92% of all participants) between 50 and 60 years of age. Interventions led by a speech language pathologist (33%) were most commonly described. Sixteen studies (59%) described primary outcomes that fit the ICF "impairment" domain. We identified few studies that explored the use, feasibility, and effectiveness of rehabilitation interventions for individuals with HNC during treatment. Future research should assess the effectiveness of rehabilitation interventions on functional outcomes beyond the ICF body function and structure domain.
Collapse
Affiliation(s)
- Brenda Kibuka Nayiga
- School of Rehabilitation Science, McMaster University, Hamilton, Ontario, Canada
| | - Sophia Werden Abrams
- School of Rehabilitation Science, McMaster University, Hamilton, Ontario, Canada
| | - Ashwak Rhayel
- School of Rehabilitation Science, McMaster University, Hamilton, Ontario, Canada
| | - Holly Edward
- School of Rehabilitation Science, McMaster University, Hamilton, Ontario, Canada
| | - Ada Tang
- School of Rehabilitation Science, McMaster University, Hamilton, Ontario, Canada
| | - Michelle E Kho
- School of Rehabilitation Science, McMaster University, Hamilton, Ontario, Canada
| | - Hotte Sebestien
- Department of Oncology, Juravinski Cancer Centre, Hamilton, Ontario, Canada
| | - Jenna Smith-Turchyn
- School of Rehabilitation Science, McMaster University, Hamilton, Ontario, Canada
| |
Collapse
|
3
|
Hu L, Xu Y, Xu Y. Application value of self-management manual combined with case management superiority model in postoperative management of nasopharyngeal carcinoma after radiotherapy. Am J Transl Res 2023; 15:4951-4961. [PMID: 37560242 PMCID: PMC10408543] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/21/2023] [Accepted: 07/06/2023] [Indexed: 08/11/2023]
Abstract
OBJECTIVE To explore the application value of the self-management manual combined with the case management model in postoperative management of nasopharyngeal carcinoma after radiotherapy. METHODS Eighty-four patients with nasopharyngeal carcinoma admitted to Yingtan People's Hospital from May 2020 to April 2022 were retrospectively included in this study. They were divided into the experimental group (receiving self-management manual combined with case management mode scheme, n=42) and the control group (receiving continuous management after conventional nasopharyngeal carcinoma radiotherapy, n=42) according to mode differences. The cancer-related fatigue [Cancer Fatigue Scale (CFS)], comfort status [General Comfort Questionnaire (GCQ)], self-management efficacy [Chinese Strategies Used by People to Promote Health (C-SUPPH)], self-care ability (self-care ability measurement), pain score [Visual analogue scale (VAS)], and quality of life [European Organization for Research and Treatment of Cancer QLQ-C30 (EORTC QLQ-C30)] were compared between the two groups after 4 weeks of radiotherapy. The adverse reactions of the two groups were recorded. Combined with periodic review and follow-up records, the prognostic factors of the two groups of patients were analyzed. RESULTS After treatment, the scores of physical fatigue (12.83±1.10), emotional fatigue (9.78±1.32), cognitive fatigue (5.62±1.31), and total score of CFS (28.24±2.26) in the experimental group were 12.83±1.10. The control group physical fatigue (13.90±1.25) points, emotional fatigue (10.55±1.40) points, cognitive fatigue (6.80±1.75) points, and total CFS (31.33±2.59) points in both groups were lower than before treatment. The experimental group was lower than the control group (ALL P<0.05). The physiological, psychological, spiritual, socio-cultural, and environmental scores of the experimental group were higher than those of the control group (all P<0.05). The scores of health knowledge, self-care skills, self-care responsibility, and self-concept score of patients in the experimental group were higher than the control group (all P<0.05). After intervention, the VAS score of the experimental group was lower than that of the control group (P<0.05). After intervention, the EORTC QLQ-C30 score of both groups increased significantly as compared with pre-intervention. The score in the experimental group was significantly higher than that in the control group [(80.05±10.72) vs (68.11±12.10), P<0.05]. Postoperative (various) adverse reactions in the experimental group were lower than the control group (all P<0.05). The factors influencing the prognosis of nasopharyngeal carcinoma patients were age, tumor stage, and intervention mode by Cox model analysis (all P<0.05). CONCLUSION The self-management manual combined with the case management mode can alleviate cancer fatigue, improve postoperative self-management ability, self-care ability, and quality of life of patients with nasopharyngeal cancer radiotherapy, reduce the occurrence of adverse reactions and improve the prognosis of patients. It is worth promoting in clinical settings.
Collapse
Affiliation(s)
- Linai Hu
- Department of Ophthalmology and Otolaryngology, Yingtan People’s HospitalYingtan 335000, Jiangxi, China
| | - Yuehong Xu
- Department of Nursing, Yingtan People’s HospitalYingtan 335000, Jiangxi, China
| | - Yueyuan Xu
- Department of Ophthalmology, Nanchang First HospitalNanchang 330008, Jiangxi, China
| |
Collapse
|
4
|
Housten AJ, Malinowski C, Paredes E, Harris CL, McNeill LH, Chavez-MacGregor M. Movement Through Chemotherapy Delay to Initiation Among Breast Cancer Patients: A Qualitative Analysis. Patient Prefer Adherence 2022; 16:749-759. [PMID: 35345541 PMCID: PMC8957340 DOI: 10.2147/ppa.s350412] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/15/2021] [Accepted: 03/08/2022] [Indexed: 11/23/2022] Open
Abstract
Purpose (Neo) adjuvant chemotherapy decreases the risk of recurrence and improves overall survival among breast cancer patients; however, delays in chemotherapy initiation are associated with adverse health outcomes. The causes of delay are complex and include interrelated social, economic, cultural, environmental, and health system factors. Project Start was a qualitative study designed to assess and identify the multilevel factors contributing to the barriers and facilitators of initiating chemotherapy. Patients and Methods Women diagnosed with primary invasive breast cancer who experienced ≥60 day delay in (neo) adjuvant chemotherapy initiation were included. Participants completed semi-structured interviews exploring barriers and facilitators to starting chemotherapy. Interviews were transcribed and coded to identify themes using the Sort and Sift, Think and Shift analytic approach. This analysis included thorough examination of the data by advancing through iterative analytic phases to identify core topics within and across transcripts. Results We enrolled (N=22) participants with median age at diagnosis 53.5 years (range 27-70) who identified as Latina (n=8), Black (n=5), and non-Latina White (n=9). Participants described a common chemotherapy initiation process reflecting their unique needs as they transitioned through four stages: 1) receiving diagnosis and treatment recommendations; 2) processing treatment options; 3) "Flipping the Switch"; and 4) activating treatment and engaging in care. Limited explicit insight into their chemotherapy delay was expressed. Engagement across the self-, family-, community-, and medical-realms revealed interlinked and pivotal sources of support that helped participants navigate toward initiating chemotherapy. Specifically, the overarching themes included logistical, emotional, financial, and social sources of support and the relationship of these sources of support to participants' perceived self-efficacy to move toward initiating treatment. Conclusion Activating women to be engaged in the treatment process across multiple levels appeared to facilitate initiating chemotherapy. Multilevel interventions that engage the patient, family, community, and medical team may support the initiation of timely chemotherapy.
Collapse
Affiliation(s)
- Ashley J Housten
- Division of Public Health Sciences, Washington University School of Medicine, St Louis, MO, USA
| | - Catalina Malinowski
- Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
| | - Edna Paredes
- Department of Health Disparities Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
| | - Cassandra L Harris
- Department of Health Disparities Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
| | - Lorna H McNeill
- Department of Health Disparities Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
| | - Mariana Chavez-MacGregor
- Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
- Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
| |
Collapse
|
5
|
Dibaj Z, Boromandfar Z, Maghsoudi J. Effect of Implementing a Life Skills Program on the Perceptions of Aging and Self-efficacy in Postmenopausal Women: A Field Trial. IRANIAN JOURNAL OF NURSING AND MIDWIFERY RESEARCH 2022; 27:157-162. [PMID: 35419262 PMCID: PMC8997178 DOI: 10.4103/ijnmr.ijnmr_3_21] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 04/07/2021] [Revised: 05/09/2021] [Accepted: 11/17/2021] [Indexed: 11/04/2022]
Abstract
Background Complications experienced by women during menopause affect their self-efficacy and can cause a negative attitude toward this period and lifestyle changes. The aim of this study was to investigate the effects of a life skills program on the perception of aging and self-efficacy in postmenopausal women. Materials and Methods This study was performed as a field trial on 70 postmenopausal women referring to Imam Ali and Navaab Safavi health centers in Isfahan, Iran, in 2018-19. The eligible subjects were randomly divided into experimental and control groups using a number table. The experimental group received the life skills program in five sessions and the control group shared their experiences in two sessions. Data were collected using a demographic characteristics form and the Ageing Perceptions Questionnaire (APQ) and General Self-Efficacy Scale (GSE) and were analyzed using descriptive and inferential statistical tests in SPSS software. Results The results revealed that the mean score of aging perception immediately and 1 month after the intervention in the experimental group was significantly lower than that in the control group (p < 0.001). There was a significant increase in the self-efficacy score in the experimental group immediately (F1,67 = 121.89, p < 0.001) and 1 month after the intervention (F1,67 = 121.89, p < 0.001) compared to the control group. Conclusions This life skills program was able to reduce the perception of aging and physical complaints during menopause and improve self-efficacy in women. Therefore, the implementation of this intervention is recommended in women.
Collapse
Affiliation(s)
- Zahra Dibaj
- Student of Psychiatric Nursing, Student Research Center, Faculty of Nursing and Midwifery, Isfahan University of Medical Sciences, Isfahan, Iran
| | - Zahra Boromandfar
- Department of Midwifery and Reproductive Health, Faculty of Nursing Midwifery, Nursing Midwifery Care Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
| | - Jahangir Maghsoudi
- Nursing and Midwifery Care Research Center, Mental Health Nursing Department, Faculty of Nursing and Midwifery, Isfahan University of Medical Sciences, Isfahan, Iran,Address for correspondence: Dr. Jahangir Maghsoudi, Mental Health Nursing Department, Faculty of Nursing and Midwifery, Isfahan University of Medical Sciences, Isfahan, Iran. E-mail:
| |
Collapse
|
6
|
Wang J, Liu G, Li X, Huangfu M, Liu Y, Li X, Yu D, Zhou L, Chen X. Curcumol simultaneously induces both apoptosis and autophagy in human nasopharyngeal carcinoma cells. Phytother Res 2021; 35:7004-7017. [PMID: 34750896 DOI: 10.1002/ptr.7321] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/22/2021] [Revised: 10/02/2021] [Accepted: 10/18/2021] [Indexed: 01/14/2023]
Abstract
Autophagy is usually considered as a protective mechanism against cell death, and in the meantime, leads to cell injury even apoptosis. Apoptosis and autophagy are very closely connected and may cooperate, coexist, or antagonize each other on progressive occurrence of cell death triggered by natural compounds. Therefore, the interplay between the two modes of death is essential for the overall fate of cancer cells. Our previous study revealed that curcumol induced apoptosis in nasopharyngeal carcinoma (NPC) cells. Recently, curcumol was found to induce autophagy in cancer cells. However, whether curcumol can induce NPC cells autophagy and the effects of autophagy on apoptosis remain elusive. In this study, we found that curcumol induced autophagy through AMPK/mTOR pathway in CNE-2 cells. Moreover, inhibiting autophagy by autophagy inhibitor 3-methyladenine (3-MA) or apoptosis inhibitor z-VAD-fmk significantly increased proliferation while attenuated apoptosis and autophagy compared with the curcumol 212 μM group. In contrast, combining curcumol with autophagy agonist rapamycin and apoptosis inducer MG132 synergized the apoptotic and autophagic effect of curcumol. Taken together, our study demonstrates that curcumol promotes autophagy in NPC via AMPK/mTOR pathway, induces autophagy enhances the activity of curcumol in NPC cells; the combination of autophagy inducer and curcumol can be a new therapeutic strategy for NPC.
Collapse
Affiliation(s)
- Juan Wang
- Department of Pharmacy, Guilin Medical University, Guilin, China.,Guangxi Key Laboratory of Molecular Medicine in Liver Injury and Repair, the Affiliated Hospital of Guilin Medical University, Guilin, China.,Guangxi Health Commission Key Laboratory of Basic Research in Sphingolipid Metabolism Related Diseases, the Affiliated Hospital of Guilin Medical University, Guilin, China.,Faculty of Basic Medicine, Guilin Medical University, Guilin, China
| | - Guoxiang Liu
- Department of Pharmacy, Guilin Medical University, Guilin, China
| | - Xiaojuan Li
- Department of Pharmacy, Guilin Medical University, Guilin, China
| | - Mengjie Huangfu
- Department of Pharmacy, Guilin Medical University, Guilin, China
| | - Yisa Liu
- Department of Pharmacy, Guilin Medical University, Guilin, China
| | - Xumei Li
- Department of Pharmacy, Guilin Medical University, Guilin, China
| | - Dan Yu
- Department of Pharmacy, Guilin Medical University, Guilin, China
| | - Luwei Zhou
- Department of Pharmacy, Guilin Medical University, Guilin, China
| | - Xu Chen
- Department of Pharmacy, Guilin Medical University, Guilin, China
| |
Collapse
|
7
|
Liu F, Fu SN, Chen YZ, Yan OY, Tong F, Peng WL, Zou R, Wen MN, Jiang L, Ma HZ, He Q, Liu L, Yang H, Huang XF, Han YQ, Wang H, Liu XH. Effects of Cognitive Behavioral Therapy for Depression and Anxiety, Response Rates and Adverse Events in Patients with Locoregional Advanced Nasopharyngeal Carcinoma. Integr Cancer Ther 2021; 20:15347354211006179. [PMID: 33784875 PMCID: PMC8020041 DOI: 10.1177/15347354211006179] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/08/2022] Open
Abstract
Purpose: This retrospective study investigated the effects of cognitive behavioral
therapy (CBT) on depression, anxiety, response rates, and adverse events in
patients with locoregional advanced nasopharyngeal carcinoma (NPC). Methods: A total of 269 patients with diagnosis of stage III-IVA NPC received either
CBT plus chemoradiotherapy (CBT group, n = 136) or treatment as usual (TAU)
plus chemoradiotherapy (TAU group, n = 133). Patients in the CBT group
received a series of 6 CBT sessions for 6 weeks during concurrent
chemoradiotherapy. Depression and anxiety were assessed using the Hospital
Anxiety and Depression Scale (HADS) score at baseline, the completion of
radiotherapy, and 6, 12, and 24 months after radiotherapy. Response rates
and adverse events were also evaluated. Results: Patients in the CBT group showed significantly less depression and anxiety
than patients in the TAU group after the completion of radiotherapy
(P < .05). Complete response rates were 99.3%
(135/136) and 92.5% (123/133) in the CBT group and TAU group with a small
effect size (Phi coefficient = .171), respectively
(P = .005). Compared with the TAU group, the CBT group
showed a significantly lower incidence of acute adverse events and late
toxic effects. Conclusions: The addition of CBT to chemoradiotherapy significantly reduced depressive and
anxiety symptoms. CBT combined with chemoradiotherapy is associated with
improved response rates, with reduced incidence of toxic effects in patients
with locoregional advanced NPC. Based on this study, we registered a
randomized controlled clinical trials to better define the role of CBT in
patients with locoregional advanced NPC (Registration number:
ChiCTR2000034701).
Collapse
Affiliation(s)
- Feng Liu
- Department of Radiation Oncology, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, China
| | - Sheng-Nan Fu
- Department of Radiation Oncology, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, China
| | - Yan-Zhu Chen
- Department of Radiation Oncology, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, China
| | - Ou-Ying Yan
- Department of Radiation Oncology, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, China
| | - Fei Tong
- Psychological Clinic, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, China
| | - Wang-Lian Peng
- Department of Hospice Unit, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, China
| | - Ran Zou
- Department of Hospice Unit, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, China
| | - Min-Ni Wen
- Department of Clinical Spiritual Care, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, China
| | - Ling Jiang
- Department of Clinical Spiritual Care, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, China
| | - Hong-Zhi Ma
- Department of Radiation Oncology, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, China
| | - Qian He
- Department of Radiation Oncology, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, China
| | - Lin Liu
- Department of Radiation Oncology, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, China
| | - Hui Yang
- Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, China
| | - Xu-Fen Huang
- Department of Hospice Unit, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, China
| | - Ya-Qian Han
- Department of Radiation Oncology, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, China
| | - Hui Wang
- Department of Radiation Oncology, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, China
| | - Xiao-Hong Liu
- Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, China
| |
Collapse
|
8
|
Lai F, Pei L, Yue S, Cao X, Xiao H, Li Y, Li J. Translation and validation of the Chinese version of medical maximizer-minimizer scale: a cross-sectional study. BMJ Open 2021; 11:e042432. [PMID: 33408206 PMCID: PMC7789444 DOI: 10.1136/bmjopen-2020-042432] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/11/2022] Open
Abstract
OBJECTIVE Medical overutilisation and underutilisation affect optimal healthcare. The Medical Maximizer-Minimizer Scale (MMS) was developed to assess individual medical maximising and minimising tendencies. Despite significant improvement in the healthcare system over the past four decades, no psychometric scales to examine treatment maximising and minimising preferences are available in China. This study aimed to translate the MMS into Chinese and examine its reliability and validity in a Chinese population. DESIGN This cross-sectional study was conducted in December 2019 through an online survey panel. METHODS The MMS was translated into a Chinese version (CN-MMS) using a forward-backward translation procedure. Next, a random online survey of the general population in China was conducted. Exploratory factor analysis (EFA) and confirmatory factor analysis were performed to examine the underlying factor structure of the CN-MMS. The internal consistency reliability of the scale was determined using Cronbach's α coefficient and corrected item-total correlation. A multivariate linear regression analysis was used to examine associations between medical maximising and minimising preferences and demographic variables in the Chinese population. RESULTS This study included 984 participants aged 18-80 years. The CN-MMS retained 10 items, and the EFA supported a two-factor structure. The model fit for this two-factor structure of the CN-MMS was acceptable with χ2/df=3.7, comparative fit index=0.958, goodness-of-fit index=0.951, Tucker-Lewis Index=0.944 and root mean square error of approximation=0.074. The scale had a Cronbach's α coefficient of 0.864, corrected item-total correlation of 0.451-0.667, and test-retest reliability of 0.815. Significant predictors of CN-MMS total score were nationality and household monthly income. CONCLUSIONS The CN-MMS showed satisfactory psychometric properties. Therefore, it can be used to investigate the individual medical maximising and minimising tendencies among the general Chinese population.
Collapse
Affiliation(s)
- Fenghua Lai
- Department of Endocrinology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
| | - Ling Pei
- Department of Endocrinology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
| | - Shufan Yue
- Department of Endocrinology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
| | - Xiaopei Cao
- Department of Endocrinology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
| | - Haipeng Xiao
- Department of Endocrinology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
| | - Yanbing Li
- Department of Endocrinology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
| | - Jin Li
- Department of Geriatrics, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
| |
Collapse
|